Most optometrists approach patient care from a clinical perspective, and rightly so. Direct examination of the eye is straightforward, painless and fruitful. However, breakthroughs in genetics and molecular biology have opened new avenues that begin at the most elemental level: our own DNA. The work of connecting these intrinsic factors to the reality of the patient in the chair is fraught with challenges—scientific, logistical, financial—but holds enormous potential, too. In fact, the first FDA-approved gene therapy was for a retinal degenerative disease. This has sparked significant interest in the role gene therapy plays in eye care, and where it’s headed in the future.
A 64-year-old Caucasian male presented to the office requesting a second opinion regarding what he described as a constant right eye turn. He explained that he realized the eye was suffering from reduced vision for approximately two years but could not elaborate on how the vision was lost. His motivation for seeking the correction was that he had recently failed the vision test for driving a school bus.
His ocular history included bilateral upper eyelid ptosis and right exotropia since childhood. He denied a history of double vision. He added that his brother and father have the same upper right eyelid presentation. He reported no systemic illness, no medications and denied allergies of any kind.
A 56-year-old Hispanic female presented with new-onset hazy vision and floaters in the left eye for the past week. She has had similar episodes in that eye before; the last one occurred six years earlier. In fact, she lost central vision in the left eye almost 20 years ago when the problem first started. The right eye was good, and she reported no problems. She reported being in good health and does not take any medications.
You’ve taken the kids for their checkups and scheduled your parents’ doctor visits. You even went along to make sure they understand what was happening.
Nikki Iravani, OD, is always on the lookout for a great marketing tip.
Nine women ODs were honored during the fourth annual Theia Awards of Excellence from Women In Optometry magazine.